Um Estudo de Investigação Piloto de Marca Aberta, para Avaliar a Segurança e Eficácia da Transplantação de Isletos Humanos Macro-encapsulados no Bioartificial Pancreas Beta-Air em Pacientes com Diabetes Mellitus de Tipo 1
NCT: NCT02064309 · ACTIVE_NOT_RECRUITING
Publicidade
Resumo breve
The primary objective of this clinical investigation is to investigate the safety of implantation of the human islet containing device Beta-Air in type 1 diabetic subjects. The secondary objective of this clinical investigation is to investigate if the transplantation of macro-encapsulated human islets within the Beta-Air device can provide improved glycaemic control in type 1 diabetes patients with reduced incidences of hypoglycaemic episodes.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.